首页> 外文期刊>Bulletin of the Korean Chemical Society >Synthesis, Characterization, and Biological Evaluation of Oxadiazole Derivatives Bearing 5-Phenyl-tetrazole as Osteoclast Differentiation Inhibitors
【24h】

Synthesis, Characterization, and Biological Evaluation of Oxadiazole Derivatives Bearing 5-Phenyl-tetrazole as Osteoclast Differentiation Inhibitors

机译:具有5-苯基-四唑作为破骨细胞分化抑制剂的恶二唑衍生物的合成,表征和生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

Novel oxadiazoles bearing 5-phenyl-tetrazole (5a-k) were designed and efficiently synthesized by treating 2-(5-phenyl-2H-tetrazole-2-yl)acetohydrazide (4) with aromatic carboxylic acids in POCl3 , and their in vitro anti-osteoclastogenic activities were evaluated. In the cell-based osteoclast differentiation model, all compounds (5a-k) inhibited the formation of osteoclasts. In addition, the potential target molecules of compound 5 analogs were predicted with their chemical substructures via a web-based interface, and some of them were found to be related to osteoclast differentiation. Consequently, the scaffold containing oxadiazole-tetrazole in a single molecule and their analogs are of potential use in the design of novel anti-osteoclastogenic therapeutics.
机译:通过在POCl3中用芳香族羧酸处理2-(5-苯基-2H-四唑-2-基)乙酰肼(4),设计并有效合成了带有5-苯基四唑(5a-k)的新型恶二唑,并在体外进行了合成评估抗破骨细胞活性。在基于细胞的破骨细胞分化模型中,所有化合物(5a-k)均抑制破骨细胞的形成。此外,还可以通过基于Web的界面预测化合物5类似物的潜在目标分子及其化学亚结构,发现其中一些与破骨细胞分化有关。因此,在单个分子中包含恶二唑-四唑的支架及其类似物在设计新型抗破骨细胞疗法中可能具有潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号